CBSE Digital Evaluation System Faces Student Backlash Over Scoring Errors Tech Billionaires Influence Trump to Withdraw AI Executive Order as MAGA Base Pushes for Regulation Smaller Robotaxi Challenger Posts Nearly 400 Revenue Growth Dwarfing Tesla in Segment Nostalgia and Speculation Fuel MultiMillion Dollar Pokmon Card Boom Jim Cramer Expresses Optimism on Palo Alto Networks PANW Amid Cybersecurity Sector Growth Core Inflation Hits 32 in March as FirstQuarter GDP Growth Slows to 2 Iran Conflict Drives Oil Prices Higher AFLAC Q1 2026 Earnings EPS Misses Estimates Amid Operating Challenges AKR Q1 2026 Earnings Earnings Beat by Wide Margin Despite Minor Stock Decline Jefferson Capital Inc JCAP Q1 2026 Earnings EPS Surpasses Estimates by 448 Amid Slight Stock Decline POET Q1 2026 Earnings Loss Widens More Than Expected Stock Declines iSpecimen Inc ISPC Q3 2024 Earnings Wide EPS Miss Amid Operational Challenges KURA Q1 2026 Earnings ClinicalStage Biotech Misses Wall Street Estimates Stock Slides CRA International CRAI Edges Higher Navigating Key Support and Resistance Levels Energy Focus EFOI Inches Higher Testing Key Resistance Near 409 Columbia Banking System COLB Edges Lower Amid Sector Headwinds Key Support Levels in Focus RLI Corp RLI Treads Water Near Key Support as Insurance Sector Faces Headwinds China SXT Pharmaceuticals SXTC Sees Uptick Amid Support Holding KFS Q1 2026 Earnings Loss Per Share of 010 Reported Stock Down Slightly Autoliv Q1 2026 Earnings Strong Earnings Beat Drives Stock Higher CVBF Q1 2026 Earnings Slight EPS Miss Amid Stable Operations Shares Edge Higher Amphastar Pharmaceuticals AMPH Q1 2026 Earnings Significant EPS Miss Fails to Dampen Stock Sentiment DNLI Q1 2026 Earnings Cost Discipline Drives EPS Beat Despite PreRevenue Status Iveda Solutions Q2 2024 Earnings EPS Beats Estimates by 412 Stock Declines SpaceX and OpenAI IPOs Could Surpass Berkshire Hathaway on Debut Day Prediction Markets Suggest QTTB Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Pipeline Progress InMed Pharmaceuticals INM Shares Slide Over 3 as Biotech Volatility Intensifies